George L. Barnes
Department of Orthopaedic Surgery
Boston University Medical Center
715 Albany Street
R-205
USA
Name/email consistency: high
- Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. Barnes, G.L., Kakar, S., Vora, S., Morgan, E.F., Gerstenfeld, L.C., Einhorn, T.A. J. Bone. Joint. Surg. Am (2008)
- Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. Barnes, G.L., Hebert, K.E., Kamal, M., Javed, A., Einhorn, T.A., Lian, J.B., Stein, G.S., Gerstenfeld, L.C. Cancer Res. (2004)
- Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Barnes, G.L., Javed, A., Waller, S.M., Kamal, M.H., Hebert, K.E., Hassan, M.Q., Bellahcene, A., Van Wijnen, A.J., Young, M.F., Lian, J.B., Stein, G.S., Gerstenfeld, L.C. Cancer Res. (2003)
- Transcriptional regulation restricting bone sialoprotein gene expression to both hypertrophic chondrocytes and osteoblasts. Barnes, G.L., Della Torre, T., Sommer, B., Young, M.F., Gerstenfeld, L.C. J. Cell. Biochem. (2002)